Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
New England Journal of MedicinePublished 4 May 2011
Anna Bill‐Axelson, Lars Holmberg, Mirja Ruutu, Hans Garmo, Jennifer R. Rider, Christer Busch
Citations1,896
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Radical prostatectomy was associated with a reduction in the rate of death from prostate cancer, and men with extracapsular tumor growth may benefit from adjuvant local or systemic treatment.
Abstract
Radical prostatectomy was associated with a reduction in the rate of death from prostate cancer. Men with extracapsular tumor growth may benefit from adjuvant local or systemic treatment. (Funded by the Swedish Cancer Society and the National Institutes of Health.).
Keywords
Medicine
The Annals of StatisticsA Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
4,891 Citations1988Malcolm H. Ray
New England Journal of MedicineRadical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
1,119 Citations2005Anna Bill‐Axelson, Lars Holmberg +12 more
Journal of Clinical OncologyClinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
1,069 Citations2009Laurence Klotz, Liying Zhang +4 more
A low rate of prostate cancer mortality was observed among the patients who were reclassified as higher risk and who were treated, PSA failure was relatively common and other-cause mortality accounted for almost all of the deaths.
The ProstateRadical prostatectomy with preservation of sexual function: Anatomical and pathological considerations
1,062 Citations1983Patrick C. Walsh, Herbert Lepor +1 more
It is shown that it is possible to cure localized prostatic cancer with surgery and maintain postoperative sexual function in men who underwent the procedure 2‐10 months previously.
Urologic Clinics of North AmericaLONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY
1,028 Citations2001Misop Han, Alan W. Partin +3 more
The proportion of men with early stage prostate cancer will continue to increase with wide use of serum PSA testing and digital rectal examination, and excellent long-term results can be obtained with RRP for early stage disease.
New England Journal of MedicineResults of Conservative Management of Clinically Localized Prostate Cancer
955 Citations1994Gerald W. Chodak, Ronald A. Thisted +8 more
The strategy of initial conservative management and delayed hormone therapy is a reasonable choice for some men with grade 1 or 2 clinically localized prostate cancer, particularly for those who have an average life expectancy of 10 years or less.
The LancetEndocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
874 Citations2008Anders Widmark, Olbjørn Klepp +9 more
In patients with locally advanced or high-risk local prostate cancer, addition of local radiotherapy to endocrine treatment halved the 10-year prostate-cancer-specific mortality, and substantially decreased overall mortality with fully acceptable risk of side-effects compared with endocrine Treatment alone.
Journal of Clinical OncologyPhase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
824 Citations2009Thomas Wiegel, Dirk Bottke +18 more
Adjuvant RT for pT3 prostate cancer with postoperatively undetectable PSA significantly reduces the risk of biochemical progression and further follow-up is needed to assess the effect on metastases-free and overall survival.
New England Journal of MedicineA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
820 Citations2002Lars Holmberg, Anna Bill‐Axelson +12 more
In this randomized trial, radical prostatectomy significantly reduced disease-specific mortality, but there was no significant difference between surgery and watchful waiting in terms of overall survival.
New England Journal of MedicineQuality of Life after Radical Prostatectomy or Watchful Waiting
726 Citations2002Gunnar Steineck, Fred Helgesen +5 more
The assignment of patients to watchful waiting or radical prostatectomy entails different risks of erectile dysfunction, urinary leakage, and urinary obstruction, but on average, the choice has little if any influence on well-being or the subjective quality of life after a mean follow-up of four years.
JNCI Journal of the National Cancer InstituteFive-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study
668 Citations2004Arnold L. Potosky, William W. Davis +5 more
At 5 years after diagnosis, men treated with radical prostatectomy for localized prostate cancer continue to experience worse urinary incontinence than men treating with external beam radiotherapy, and the two treatment groups were more similar to each other with respect to overall sexual function.
The Journal of UrologyPredicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
638 Citations2011Scott E. Eggener, Peter T. Scardino +13 more
Poorly differentiated cancer and seminal vesicle invasion are the prime determinants of prostate cancer specific mortality after radical prostatectomy and can be predicted with remarkable accuracy after the pathological features of prostatecancer are known.
JNCI Journal of the National Cancer InstituteRadical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial
602 Citations2008Anna Bill‐Axelson, L. Holmberg +13 more
Radical prostatectomy reduces prostate cancer mortality and risk of metastases with little or no further increase in benefit 10 or more years after surgery.
JAMAFifteen-Year Survival in Prostate Cancer<subtitle>A Prospective, Population-Based Study in Sweden</subtitle>
427 Citations1997Jan-Erik Johansson
Patients with localized prostate cancer have a favorable outlook following watchful waiting, and the number of deaths potentially avoidable by radical initial treatment is limited, according to a population-based cohort study.
JAMASurvival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
305 Citations2006Yu-Ning Wong, Nandita Mitra +6 more
A survival advantage is associated with active treatment for low- and intermediate-risk prostate cancer in elderly men aged 65 to 80 years, and a benefit associated with treatment was seen in all subgroups examined.
Health Technology AssessmentProstate Testing for Cancer and Treatment (ProtecT) feasibility study
290 Citations2003Jenny Donovan, Freddie C. Hamdy +13 more
CancerRecent results of management of palpable clinically localized prostate cancer
146 Citations1993Jan Adolfsson, Gunnar Steineck +1 more
There is uncertainty regarding if, when, and how localized prostate cancer should be managed, so patients should be aware of the risks and take care of themselves and their health.
CancerThe role of radical prostatectomy in the management of prostatic cancer
132 Citations1987Patrick C. Walsh, Herbert Lepor
It appears possible today to preserve sexual function in a majority of patients undergoing radical prostatectomy without compromising the cancer operation, an observation that may encourage more physicians to take greater interest in diagnosing prostatic cancer in young men at a stage when it is still curable.
The Journal of UrologyStaging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
109 Citations1980Charles B. Brendler, Laurence K. Cleeve +2 more
Limited staging pelvic node dissection provides information regarding nodal dissection similar to that identified after more extensive dissection and it can be accomplished with little morbidity.
Histological Typing of Prostate Tumours
108 Citations2002F. K. Mostofi, Sesterhenn Ia +1 more
The TNM Classification of Tumours of the Prostate shows clear trends in benign and malignant cases, and these trends are likely to continue to improve in the coming years.
European UrologyTime, Symptom Burden, Androgen Deprivation, and Self-Assessed Quality of Life after Radical Prostatectomy or Watchful Waiting: The Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) Clinical Trial
102 Citations2008Eva Johansson, Anna Bill‐Axelson +4 more
Quality of life was lower with longer follow-up time in both groups and was statistically significant in the watchful waiting group, while the number of physical symptoms was associated with the level of quality of life.
International Journal of Radiation Oncology*Biology*PhysicsPhase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02
66 Citations2008Seth A. Rosenthal, Kyoungwha Bae +7 more
TEE was associated with significantly increased toxicity during treatment and the toxicity profiles did not differ at 2 and 3 years after therapy, so excess long-term toxicity was not observed in Arm 2.
PubMedActive surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis.
40 Citations2006Laurence Klotz, Robert K. Nam
Acta OncologicaThe prostate cancer pseudo-epidemic
23 Citations2010Hans‐Olov Adami
It is proposed that the mortality reduction following PSA screening is probably modest, whilst substantial harms are well documented, and the growing number of health and professional agencies that advise against population screening with PSA should be concurred with.